While Aurora Cannabis’ (TSE:ACB) stock price does not reflect great confidence and Evotec’ (ETR: EVT) figures in the last quarter experienced a small increase, World High Life PLC (NEX:LIFE) remains the star company that investors should pay attention to.
The overall environment for equities remains positive. The stock indices are obviously still aiming upwards. The current quarterly reporting season was able to set positive trends on both sides of the Atlantic and thus make a significant contribution to the current recovery on the stock markets. And companies’ quarterly results are still “trickling in”.
Evotec’ business development in the last quarter
On November 12, the German biotechnology group Evotec presented its results for the third quarter and the first nine months of 2019, respectively. It will be interesting to see whether the figures, which at first glance seemed to have fallen, will also be able to give fresh impetus to the stock price, which had suffered in recent weeks and could now urgently need positive accents.
Evotec itself was quite satisfied with the data and business development. For the first nine months of 2019, the company reported sales of $353.96 million (€321.4 million), an increase of 16% compared to the first nine months of the previous year. Adjusted EBITDA (earnings before interests, taxes, depreciation and amortization) increased by 36% year-on-year to $102.65 million (€93.2 million). The initial reaction of market participants to the figures and the accompanying comments was positive. The stock price increased slightly.
The Canadian cannabis producer Aurora Cannabis is also hoping for fresh impetus
Aurora Cannabis has announced its data for the September quarter (equivalent to the 1st quarter of the fiscal year 2020) for November 14, 2019. The cannabis sector as a whole and the stock itself are still in the midst of a pronounced correction. In this respect, the upcoming figures for Aurora Cannabis will be looked at very closely. And the current share price development does not necessarily reflect great confidence.
During the last trading days a comparatively narrow trading range was established. It is possible that the publication of the company’s quarterly figures will lead to their dissolution. However, the direction is still open. The most recent trading trend made it clear that values of above $3.77 (CA$5.0) are difficult to sustain. On the downside, the 52-week low of just under $3.47 (CA$4.6) should not be undercut at all. Otherwise, things could get hot again.
World High Life – an enticing opportunity for investors
As the North-American cannabis sector is becoming more and more crowded each day, investors are eyeing new frontier markets to bet on. Europe is the most promising cannabis market at the moment, with several countries relaxing their policy toward cannabis use.
World High Life PLC (NEX:LIFE) is a UK-based company founded by two experienced North Americans, the founders of Supreme Cannabis (TSX: FIRE) and 1933 Industries (CSE:TGIF), who bring the know-how and hard-won decades of experience to the burgeoning European cannabis market.
World High Life is not just another cannabis company, it is an investment company that offers a unique opportunity to investors interested in the cannabis business. WHL’s strategic plan is to identify and acquire the European and UK-based cannabis companies with potential of becoming dominant players in the industry.
In this respect, WHL has just acquired UK’s leading CBD company Love Hemp Ltd. in a transaction valued at 9 million GBP. Love Hemp produces a variety of CBD products such as sprays, vapes, oils, edibles, CBD-infused beverages, and cosmetics and sells its products in 1,200 UK high street stores. Additionally, they have agreements with big networks such as Boots, Tesco, Superdrug and Sainsbury’s.
By purchasing a single stock, investors will be able to access a portfolio of top companies, avoiding, with minimum risk. WHL’s experts will assure you won’t miss out on the new opportunities that will continue to occur in the European cannabis market.
Medical cannabis and CBD market in the UK and Europe is expected to reach 58 billion euro by 2029, and companies like World High Life PLC are set to dominate it.
